275 related articles for article (PubMed ID: 11706322)
1. The clinical use of colistin in patients with cystic fibrosis.
Beringer P
Curr Opin Pulm Med; 2001 Nov; 7(6):434-40. PubMed ID: 11706322
[TBL] [Abstract][Full Text] [Related]
2. [Practical guideline for the use of colistin].
Dijkmans AC; Wilms EB; Kamerling IM; Birkhoff W; van Nieuwkoop C; Verbrugh HA; Touw DJ
Ned Tijdschr Geneeskd; 2014; 158():A7445. PubMed ID: 25322351
[TBL] [Abstract][Full Text] [Related]
3. [Inhaled colistin in cystic fibrosis].
Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
[TBL] [Abstract][Full Text] [Related]
4. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
5. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.
Conway SP; Pond MN; Watson A; Etherington C; Robey HL; Goldman MH
Thorax; 1997 Nov; 52(11):987-93. PubMed ID: 9487348
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of colistin in cystic fibrosis patients.
Bosso JA; Liptak CA; Seilheimer DK; Harrison GM
DICP; 1991 Nov; 25(11):1168-70. PubMed ID: 1763528
[TBL] [Abstract][Full Text] [Related]
7. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Bozkurt-Güzel C; Gerçeker AA
J Antibiot (Tokyo); 2012 Feb; 65(2):83-6. PubMed ID: 22126897
[No Abstract] [Full Text] [Related]
8. Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.
Bergen PJ; Tsuji BT; Bulitta JB; Forrest A; Jacob J; Sidjabat HE; Paterson DL; Nation RL; Li J
Antimicrob Agents Chemother; 2011 Dec; 55(12):5685-95. PubMed ID: 21911563
[TBL] [Abstract][Full Text] [Related]
9. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.
Young DC; Zobell JT; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
Pediatr Pulmonol; 2013 Jan; 48(1):1-7. PubMed ID: 22949160
[TBL] [Abstract][Full Text] [Related]
10. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N
Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
[TBL] [Abstract][Full Text] [Related]
11. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
[TBL] [Abstract][Full Text] [Related]
12. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician.
Martis N; Leroy S; Blanc V
J Infect; 2014 Jul; 69(1):1-12. PubMed ID: 24631777
[TBL] [Abstract][Full Text] [Related]
13. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
14. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
[TBL] [Abstract][Full Text] [Related]
15. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
[TBL] [Abstract][Full Text] [Related]
16. [Colistin as last resort in 2 patients with pulmonary infection with multiresistant nosocomial bacteria].
Ekkelenkamp MB; Bonten MJ
Ned Tijdschr Geneeskd; 2006 May; 150(18):1022-6. PubMed ID: 16715867
[TBL] [Abstract][Full Text] [Related]
17. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
Berlana D; Llop JM; Manresa F; Jódar R
Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
19. Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis.
Ali H; Orchard C; Mariveles M; Scott S; Alshafi K; Bilton D; Simmonds N
Eur Respir J; 2015 Sep; 46(3):862-5. PubMed ID: 25882803
[No Abstract] [Full Text] [Related]
20. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
